RE:IPA Announces Agreement to Acquire BioStrand BV – RevolutionAlthough volume is still light, the market seems to like this acquisition:
- It'll separate them from the pack
- It's not too dilutive (20%). Mostly acquired thru the issuance of more shares
- Doesn't zap much of the large cash reserves.
It's only a matter of time before they hit on a formula with a major. Then investors will be scrambling to get in.
In the meantime - it's very cheap - especially for a multi-candidate, existing CRO business, and especially if you believe (as I do), that Covid is not done with us yet.
MM